Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

232.77 +4.60 (+2.02%)
Official Closing Price Updated: 7:00 PM EDT, Jun 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Why Johnson & Johnson May Be the Closest Thing Investors Can Find to a Bulletproof Dividend Stock ↗
Johnson & Johnson takes a licking, and the dividend keeps on ticking higher. 
Via The Motley Fool
Topics Death
Exploring the top movers within the dow jones index during today's session. ↗
Via Chartmill
Friday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
These dow jones stocks are moving in today's session ↗
Via Chartmill
Johnson & Johnson (NYSE:JNJ): A Classic Dividend Stock for Sustainable Passive Income ↗
Via Chartmill
Top dow jones movers in Thursday's session ↗
Via Chartmill
News headline image
Why Is Laser Photonics Stock Falling On Thursday? ↗
Laser Photonics Corp (NASDAQ:LASE) stock dips on Thursday. Read why traders are taking profits ahead of Q1 earnings despite major Department of War and Johnson & Johnson deals. 
Via Benzinga
What's going on in today's session: dow jones movers ↗
Via Chartmill
Top dow jones movers in Wednesday's session ↗
Via Chartmill
News headline image
1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't ↗
This particular sector may suit cautious and aggressive investors. 
Via The Motley Fool
News headline image
Buy 2 Vanguard Index Funds to Beat the S&P 500 in the Next Year, According to Wall Street ↗
Wall Street analysts expect market-beating returns from healthcare and communication services stocks over the next year. 
Via The Motley Fool
Topics ETFs Intellectual Property Stocks
News headline image
Johnson & Johnson Hopes to Dethrone AbbVie's Biggest Growth Driver. Here's Why Investors Shouldn't Panic ↗
AbbVie's shareholders can sleep easy. 
Via The Motley Fool
News headline image
U.S. Health Care Depth or Global Industry Reach? VHT vs. IXJ ↗
The Vanguard Health Care ETF (VHT) and the iShares Global Healthcare ETF (IXJ) both target health care stocks, but they are tailored to different investor needs. One emphasizes broad, low-cost U.S.... 
Via The Motley Fool
Topics ETFs Intellectual Property
News headline image
Legend Biotech Conference Spotlights CARVYKTI’s Curative Potential, Earlier Use ↗
Legend Biotech (NASDAQ:LEGN) used an investor and analyst event to highlight long-term data and physician perspectives supporting broader use of CARVYKTI, its BCMA-directed CAR T-cell therapy for... 
Via MarketBeat
News headline image
3 Dividend Kings That Earn Their Crown Every Quarter ↗
These 3 Dividend Kings combine decades of dividend growth with strong fundamentals, recession resistance, and long-term income potential 
Via MarketBeat
Topics Economy
News headline image
How to Recession-Proof Your Retirement Income Before Summer 2026 ↗
High energy prices have investors worried about a recession; these businesses should survive the hit just fine. 
Via The Motley Fool
Topics Economy Retirement
News headline image
This Dividend King Stock Just Offered a Superb Buy-the-Dip Opportunity ↗
Walmart is facing short-term pressures that are leading investors to miss the long-term opportunity. 
Via The Motley Fool
Which dow jones stocks are moving on Friday? ↗
Via Chartmill
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
News headline image
VYM vs. SCHD: Which U.S. Dividend ETF Is a Better Buy? ↗
When choosing dividend ETFs, diversification is a top priority. 
Via The Motley Fool
Topics ETFs
News headline image
Is Johnson & Johnson Stock Outperforming the Dow?
Johnson & Johnson has outperformed the Dow Jones over the past year, and analysts remain moderately optimistic about the stock’s outlook. 
Via Barchart.com
Topics Stocks
News headline image
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
From Johnson & Johnson
Via Business Wire
News headline image
President Trump's Drug Pricing Policies Could Hurt Drugmakers' Profits. Time to Sell Pharma Stocks? ↗
Don't be too quick to give up on the industry. 
Via The Motley Fool
Topics Economy Government
News headline image
Why Johnson & Johnson Might Be the Smartest Dividend King to Buy in Today's Market ↗
Johnson & Johnson sells products that are necessities, not just nice-to-haves. 
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
A Quiet Trim From LEVIN — O-I Glass Faces Bigger Questions ↗
O-I Glass manufactures glass containers for food and beverage makers across the Americas, Europe, and Asia Pacific. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Healthcare Stocks Are on Fire -- Don't Miss These Opportunities ↗
The healthcare sector outperformed the rest of the market over the past week. 
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
These 3 Dividend Stocks Are as Close to a Sure Thing as Investing Gets ↗
ExxonMobil, Johnson & Johnson, and Coca-Cola are safe stocks to buy and forget. 
Via The Motley Fool
Topics ETFs Energy
News headline image
3 Dividend Kings to Buy and Hold for 20 Years ↗
When it comes to reliable dividend payouts, these three companies keep rewarding their long-term shareholders. 
Via The Motley Fool
Topics Retirement
News headline image
Meet the Dividend King With a Higher Credit Rating Than the U.S. Government ↗
It has plenty of other qualities investors should take note of. 
Via The Motley Fool
Topics Economy
News headline image
3 Dividend Stocks Warren Buffett Would Buy in a Market Crash ↗
Get greedy for these blue chip dividend stocks when Wall Street gets fearful. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.